[Osteoporotic changes in rheumatoid arthritis].

Area of Science:

• Rheumatology
• Osteoporosis Research
• Bone Metabolism

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease.
• RA can affect bone health, but the relationship with osteoporosis is complex.
• Corticosteroid treatment, common in RA, is known to cause bone loss, but this study excluded such patients.

Purpose of the Study:

• To investigate bone mineral density (BMD) in female patients with rheumatoid arthritis (RA) not treated with corticosteroids.
• To determine factors influencing bone loss in RA patients, including menopausal status, disease duration, and joint destruction.
• To differentiate bone loss patterns between premenopausal and postmenopausal RA patients.

Main Methods:

• Single photon absorptiometry was used to measure BMD at the distal radius (1/6 and 1/3 sites).
• Fifty-eight female patients with RA, untreated with corticosteroids, were included.
• Data were compared with age-matched controls, and correlations with disease duration and joint destruction were analyzed.

Main Results:

• Half of the RA patients exhibited lower BMD than controls.
• BMD reduction was more pronounced in postmenopausal patients with advanced radiocarpal joint destruction.
• A significant inverse correlation was found between BMD and disease duration; bone loss accelerated in postmenopausal women.

Conclusions:

• Rheumatoid arthritis is not universally associated with osteoporosis.
• Osteoporosis risk is elevated in postmenopausal RA patients with prolonged disease and significant joint damage.
• Bone loss in premenopausal RA patients primarily affects periarticular regions, while postmenopausal patients experience both periarticular and diaphyseal bone loss.